Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Board Committee changes

10th Dec 2015 11:51

RNS Number : 6618I
GlaxoSmithKline PLC
10 December 2015
 

 

GlaxoSmithKline plc

Board Committee changes

GlaxoSmithKline plc (the "Company") announces that Vindi Banga, Senior Independent Director designate and Independent Non-Executive Director, has been appointed a member of the Audit & Risk, Nominations and Remuneration Committees with effect from 1 January 2016.

 

 

V A Whyte

Company Secretary

 

10 December 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPKKDQDBDDFBD

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77